NAFTNet retrospective report on the treatment of anti-Ro/SSA mediated fetal heart block with dexamethasone

Author(s):  
Sherzana Sunderji ◽  
Shabnam Peyvandi ◽  
Edgar Jaeggi ◽  
Anita Szwast ◽  
Greg Ryan ◽  
...  
2019 ◽  
Vol 220 (1) ◽  
pp. S169-S170
Author(s):  
Sherzana Sunderji ◽  
Edgar Jaeggi ◽  
Greg Ryan ◽  
Francine Tessier ◽  
Saad Siddiqui ◽  
...  

2017 ◽  
Vol 50 ◽  
pp. 73-73
Author(s):  
A. Yulia ◽  
D. Wiliams ◽  
P. Pandya
Keyword(s):  

Author(s):  
Fuanglada Tongprasert ◽  
Kasemsri Srisupundit ◽  
Suchaya Leuwan ◽  
Kuntharee Traisrisilp ◽  
Phudit Jatavan ◽  
...  

Simple assessment of FHR baseline variability can differentiate second degree heart block (SHB) from complete heart block (CHB). In cases of SHB, antepartum NST can be reliably used for fetal surveillance. Intrapartum assessment of FHR variability as well as accelerations is useful to select cases for safe vaginal delivery


1996 ◽  
Vol 175 (2) ◽  
pp. 502-503 ◽  
Author(s):  
J.S. Carvalho ◽  
E.A. Shinebourne ◽  
P. Kyle
Keyword(s):  

2014 ◽  
Vol 44 (S1) ◽  
pp. 11-11
Author(s):  
J.A. Copel ◽  
P. Izminly ◽  
N. Costedoat-Chalumeau ◽  
A. Saxena ◽  
A. Zinc ◽  
...  
Keyword(s):  

2002 ◽  
Vol 100 (5, Part 2) ◽  
pp. 1087-1089
Author(s):  
Vatche A. Minassian ◽  
Allahyar Jazayeri

2005 ◽  
Vol 25 (12) ◽  
pp. 1129-1132 ◽  
Author(s):  
A. Sciarrone ◽  
B. Masturzo ◽  
G. Botta ◽  
S. Bastonero ◽  
M. Campogrande ◽  
...  

1979 ◽  
Vol 98 (4) ◽  
pp. 505-509 ◽  
Author(s):  
James P. Madison ◽  
Pradub Sukhum ◽  
Daryl P. Williamson ◽  
Brian C. Campion
Keyword(s):  

Author(s):  
Milene Carvalho Carrilho ◽  
Nathalie Jeanne Bravo-Valenzuela ◽  
Edward Araujo Júnior

AbstractThe present report describes a case of complete atrioventricular block (CAVB) diagnosed at 25 weeks of gestation in a pregnant woman with Sjögren's syndrome and positive anti-Ro/SSA antibodies. Fluorinated steroids (dexamethasone and betamethasone) and terbuline were used to increase the fetal heart rate, but the fetal heart block was not reversible, and the administration of drugs was discontinued due to maternal collateral effects. Follow-up fetal echocardiograms were performed, and the fetus evolved with pericardial effusion, presence of fibroelastosis in the right ventricle, and ventricular dysfunction. Interruption of pregnancy by cesarean section was indicated at 34 weeks of gestation, and a cardiac pacemaker was implanted in the male newborn immediately after birth. Therapy for fetuses with CAVB is controversial mainly regarding the use or not of corticosteroids; however, monitoring of the atrioventricular interval by fetal echocardiography should be performed in fetuses from pregnant women with positive autoantibodies anti-Ro/SSA and/or anti-La/SSB to prevent the progression to CAVB.


Sign in / Sign up

Export Citation Format

Share Document